If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
689.00    2.00 (0.29%)
Bid:
684.00
Ask:
694.00
Spread: 10.00 (1.462%)
Market Cap: £242.80m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Director/PDMR Shareholding

27 Mar 2025 07:00

RNS Number : 3918C
B.P. Marsh & Partners PLC
27 March 2025
 

27 March 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh" or the "Company")

Issue of Share Options & Director/PDMR Dealings

 

B.P. Marsh, the specialist investor in early-stage financial services businesses, announces the granting of an aggregate of 490,000 Options over ordinary shares of 10p each in the Company to certain Directors and other employees of the Company.

 

The 490,000 Options were granted following the lapse of 490,000 Options, 400,000 of which had previously been granted to former Persons Discharging Managerial Responsibilities ("PDMR") as announced on 15 November 2023. The total number of Options that have been granted (being 1,685,000) remains unchanged.

 

Certain Directors who are PDMRs have been awarded Options with details of those awards in the disclosure notices below. The remaining Options have been granted to other employees of B.P. Marsh.

 

The Options have been granted under, and will vest in accordance with, the Company's existing Share Option Plan (the "Plan"), as announced on 15 November 2023 and 20 November 2023.

 

The total number of Options granted under the Plan represents approximately 4.35% of the fully diluted shares outstanding.

 

For further information, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

    

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alice Foulk

2

Reason for notification

a)

Position / status

Managing Director (PDMR)

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Grant of Share Options as part of the Share Option Plan

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

10p

90,000

d)

Aggregated information

N/A (single transaction)

e)

Date of the transaction

27/03/25

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Daniel Topping

2

Reason for notification

a)

Position / status

Chief Investment Officer (PDMR)

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Grant of Share Options as part of the Share Option Plan

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

10p

90,000

d)

Aggregated information

N/A (single transaction)

e)

Date of the transaction

27/03/25

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Francesca Chappell

2

Reason for notification

a)

Position / status

Group Finance Director (PDMR)

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Grant of Share Options as part of the Share Option Plan

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

10p

62,500

d)

Aggregated information

N/A (single transaction)

e)

Date of the transaction

27/03/25

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for over ten years. 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBCGDXRDDDGUL
Date   Source Headline
13th Jun 20237:00 amRNSFinal Results
7th Jun 20235:39 pmRNSHolding(s) in Company
6th Jun 20234:05 pmRNSTransaction in Own Shares
6th Jun 20237:00 amRNSUse of Proceeds of Sale & Strategy Update
30th May 202310:18 amRNSTransaction in Own Shares
26th May 20239:40 amRNSTransaction in Own Shares
25th May 20233:11 pmRNSTransaction in Own Shares
23rd May 20232:49 pmRNSNotice of Annual Results and Investor Presentation
23rd May 20237:00 amRNSSale of Shareholding in Kentro Capital Limited
15th May 202310:59 amRNSTransaction in Own Shares
28th Apr 20235:11 pmRNSTransaction in Own Shares
28th Apr 20232:01 pmRNSNew Investment
26th Apr 20234:26 pmRNSTransaction in Own Shares
25th Apr 20235:42 pmRNSTransaction in Own Shares
25th Apr 20237:00 amRNSShare Buy-Back Programme Update
20th Apr 20234:49 pmRNSDirector/PDMR Shareholding
20th Apr 20233:10 pmRNSTransaction in Own Shares
19th Apr 20233:55 pmRNSTransaction in Own Shares
18th Apr 20236:04 pmRNSAward of Shares under Share Incentive Plan
17th Apr 20234:58 pmRNSTransaction in Own Shares
13th Apr 20233:28 pmRNSTransaction in Own Shares
12th Apr 20232:17 pmRNSTransaction in Own Shares
6th Apr 20233:56 pmRNSTransaction in Own Shares
5th Apr 20235:14 pmRNSTransaction in Own Shares
5th Apr 20234:12 pmRNSTransfer of Treasury Shares
4th Apr 20234:30 pmRNSTransaction in Own Shares
30th Mar 202310:30 amRNSTransaction in Own Shares
21st Mar 20232:14 pmRNSTransaction in Own Shares
20th Mar 20232:07 pmRNSTransaction in Own Shares
14th Mar 20234:00 pmRNSTransaction in Own Shares
14th Mar 20233:40 pmRNSTransaction in Own Shares
10th Mar 20232:19 pmRNSTransaction in Own Shares
7th Mar 20239:22 amRNSTransaction in Own Shares
3rd Mar 20239:58 amRNSTransaction in Own Shares
2nd Mar 20239:22 amRNSTransaction in Own Shares
1st Mar 20239:10 amRNSTransaction in Own Shares
27th Feb 20231:08 pmRNSTransaction in Own Shares
22nd Feb 20235:21 pmRNSTransaction in Own Shares
21st Feb 20234:31 pmRNSTransaction in Own Shares
21st Feb 20239:13 amRNSTransaction in Own Shares
16th Feb 20233:56 pmRNSTransaction in Own Shares
16th Feb 20238:52 amRNSTransaction in Own Shares
14th Feb 20234:40 pmRNSTransaction in Own Shares
14th Feb 20234:39 pmRNSTransaction in Own Shares
14th Feb 20237:00 amRNSTrading Update
9th Feb 202310:58 amRNSTransaction in Own Shares
6th Feb 20234:15 pmRNSInvestee Company Update - XPT Group LLC
3rd Feb 20239:22 amRNSTransaction in Own Shares
27th Jan 20232:17 pmRNSTransaction in Own Shares
25th Jan 20235:04 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.